Neurodegeneration in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9orf72 is linked to TDP-43 pathology and not associated with aggregated forms of dipeptide repeat proteins
Aims A hexanucleotide expansion in C9orf72 is the major genetic cause of inherited behavioural variant Frontotemporal dementia (bvFTD) and motor neurone disease (MND), although the pathological mechanism(s) underlying disease remains uncertain. Methods Using antibodies to poly‐GA, poly‐GP, poly‐GR,...
Saved in:
Published in | Neuropathology and applied neurobiology Vol. 42; no. 3; pp. 242 - 254 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.04.2016
Wiley Subscription Services, Inc John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Aims
A hexanucleotide expansion in C9orf72 is the major genetic cause of inherited behavioural variant Frontotemporal dementia (bvFTD) and motor neurone disease (MND), although the pathological mechanism(s) underlying disease remains uncertain.
Methods
Using antibodies to poly‐GA, poly‐GP, poly‐GR, poly‐AP and poly‐PR proteins, we examined sections of cerebral cortex, hippocampus, thalamus, cerebellum and spinal cord, from 20 patients with bvFTD and/or MND bearing an expansion in C9orf72 for aggregated deposits of dipeptide repeat proteins (DPR).
Results
Antibodies to poly‐GA, poly‐GP and poly‐GR detected numerous rounded cytoplasmic inclusions (NCI) within granule cells of hippocampal dentate gyrus and those of the cerebellum, as well as ‘star‐burst’ shaped NCI in pyramidal neurones of CA3/4 region of hippocampus. NCI were uncommon in Purkinje cells, and only very rarely seen in anterior horn cells. Poly‐PA antibody detected occasional NCI within CA3/4 neurones alone, whereas poly‐PR antibody did not identify any NCI but immunostained the nucleus of anterior horn cells, CA3/4 neurones and Purkinje cells, in patients with or without expansion in C9orf72, as well as in normal controls. Poly‐GA antibody generally detected more DPR than poly‐GP, which in turn was greater than poly‐GR. All patients with bvFTD + MND or MND showed plentiful p62/TDP‐43 positive inclusions in remaining anterior horn cells.
Conclusion
Degeneration and loss of anterior horn cells associated with expansions in C9orf72 occurs in the absence of DPR, and implies that changes involving loss of nuclear staining for and a cytoplasmic aggregation of TDP‐43 are more likely to be the cause of this.
Abundant dipeptide repeat aggregates in regions without neurodegeneration and the sparsity of inclusions in lower motor neurons in cases with motor neuron disease support the conclusion that dipeptide repeat pathology is not the direct cause of neurodegeneration. |
---|---|
AbstractList | Aims A hexanucleotide expansion in C9orf72 is the major genetic cause of inherited behavioural variant Frontotemporal dementia (bvFTD) and motor neurone disease (MND), although the pathological mechanism(s) underlying disease remains uncertain. Methods Using antibodies to poly-GA, poly-GP, poly-GR, poly-AP and poly-PR proteins, we examined sections of cerebral cortex, hippocampus, thalamus, cerebellum and spinal cord, from 20 patients with bvFTD and/or MND bearing an expansion in C9orf72 for aggregated deposits of dipeptide repeat proteins (DPR). Results Antibodies to poly-GA, poly-GP and poly-GR detected numerous rounded cytoplasmic inclusions (NCI) within granule cells of hippocampal dentate gyrus and those of the cerebellum, as well as 'star-burst' shaped NCI in pyramidal neurones of CA3/4 region of hippocampus. NCI were uncommon in Purkinje cells, and only very rarely seen in anterior horn cells. Poly-PA antibody detected occasional NCI within CA3/4 neurones alone, whereas poly-PR antibody did not identify any NCI but immunostained the nucleus of anterior horn cells, CA3/4 neurones and Purkinje cells, in patients with or without expansion in C9orf72, as well as in normal controls. Poly-GA antibody generally detected more DPR than poly-GP, which in turn was greater than poly-GR. All patients with bvFTD + MND or MND showed plentiful p62/TDP-43 positive inclusions in remaining anterior horn cells. Conclusion Degeneration and loss of anterior horn cells associated with expansions in C9orf72 occurs in the absence of DPR, and implies that changes involving loss of nuclear staining for and a cytoplasmic aggregation of TDP-43 are more likely to be the cause of this. A hexanucleotide expansion in C9orf72 is the major genetic cause of inherited behavioural variant Frontotemporal dementia (bvFTD) and motor neurone disease (MND), although the pathological mechanism(s) underlying disease remains uncertain. Using antibodies to poly-GA, poly-GP, poly-GR, poly-AP and poly-PR proteins, we examined sections of cerebral cortex, hippocampus, thalamus, cerebellum and spinal cord, from 20 patients with bvFTD and/or MND bearing an expansion in C9orf72 for aggregated deposits of dipeptide repeat proteins (DPR). Antibodies to poly-GA, poly-GP and poly-GR detected numerous rounded cytoplasmic inclusions (NCI) within granule cells of hippocampal dentate gyrus and those of the cerebellum, as well as 'star-burst' shaped NCI in pyramidal neurones of CA3/4 region of hippocampus. NCI were uncommon in Purkinje cells, and only very rarely seen in anterior horn cells. Poly-PA antibody detected occasional NCI within CA3/4 neurones alone, whereas poly-PR antibody did not identify any NCI but immunostained the nucleus of anterior horn cells, CA3/4 neurones and Purkinje cells, in patients with or without expansion in C9orf72, as well as in normal controls. Poly-GA antibody generally detected more DPR than poly-GP, which in turn was greater than poly-GR. All patients with bvFTD + MND or MND showed plentiful p62/TDP-43 positive inclusions in remaining anterior horn cells. Degeneration and loss of anterior horn cells associated with expansions in C9orf72 occurs in the absence of DPR, and implies that changes involving loss of nuclear staining for and a cytoplasmic aggregation of TDP-43 are more likely to be the cause of this. Aims A hexanucleotide expansion in C9orf72 is the major genetic cause of inherited behavioural variant Frontotemporal dementia (bvFTD) and motor neurone disease (MND), although the pathological mechanism(s) underlying disease remains uncertain. Methods Using antibodies to poly-GA, poly-GP, poly-GR, poly-AP and poly-PR proteins, we examined sections of cerebral cortex, hippocampus, thalamus, cerebellum and spinal cord, from 20 patients with bvFTD and/or MND bearing an expansion in C9orf72 for aggregated deposits of dipeptide repeat proteins (DPR). Results Antibodies to poly-GA, poly-GP and poly-GR detected numerous rounded cytoplasmic inclusions (NCI) within granule cells of hippocampal dentate gyrus and those of the cerebellum, as well as 'star-burst' shaped NCI in pyramidal neurones of CA3/4 region of hippocampus. NCI were uncommon in Purkinje cells, and only very rarely seen in anterior horn cells. Poly-PA antibody detected occasional NCI within CA3/4 neurones alone, whereas poly-PR antibody did not identify any NCI but immunostained the nucleus of anterior horn cells, CA3/4 neurones and Purkinje cells, in patients with or without expansion in C9orf72, as well as in normal controls. Poly-GA antibody generally detected more DPR than poly-GP, which in turn was greater than poly-GR. All patients with bvFTD + MND or MND showed plentiful p62/TDP-43 positive inclusions in remaining anterior horn cells. Conclusion Degeneration and loss of anterior horn cells associated with expansions in C9orf72 occurs in the absence of DPR, and implies that changes involving loss of nuclear staining for and a cytoplasmic aggregation of TDP-43 are more likely to be the cause of this. Abundant dipeptide repeat aggregates in regions without neurodegeneration and the sparsity of inclusions in lower motor neurons in cases with motor neuron disease support the conclusion that dipeptide repeat pathology is not the direct cause of neurodegeneration. Aims A hexanucleotide expansion in C9orf72 is the major genetic cause of inherited behavioural variant Frontotemporal dementia (bvFTD) and motor neurone disease (MND), although the pathological mechanism(s) underlying disease remains uncertain. Methods Using antibodies to poly‐GA, poly‐GP, poly‐GR, poly‐AP and poly‐PR proteins, we examined sections of cerebral cortex, hippocampus, thalamus, cerebellum and spinal cord, from 20 patients with bvFTD and/or MND bearing an expansion in C9orf72 for aggregated deposits of dipeptide repeat proteins (DPR). Results Antibodies to poly‐GA, poly‐GP and poly‐GR detected numerous rounded cytoplasmic inclusions (NCI) within granule cells of hippocampal dentate gyrus and those of the cerebellum, as well as ‘star‐burst’ shaped NCI in pyramidal neurones of CA3/4 region of hippocampus. NCI were uncommon in Purkinje cells, and only very rarely seen in anterior horn cells. Poly‐PA antibody detected occasional NCI within CA3/4 neurones alone, whereas poly‐PR antibody did not identify any NCI but immunostained the nucleus of anterior horn cells, CA3/4 neurones and Purkinje cells, in patients with or without expansion in C9orf72, as well as in normal controls. Poly‐GA antibody generally detected more DPR than poly‐GP, which in turn was greater than poly‐GR. All patients with bvFTD + MND or MND showed plentiful p62/TDP‐43 positive inclusions in remaining anterior horn cells. Conclusion Degeneration and loss of anterior horn cells associated with expansions in C9orf72 occurs in the absence of DPR, and implies that changes involving loss of nuclear staining for and a cytoplasmic aggregation of TDP‐43 are more likely to be the cause of this. Abundant dipeptide repeat aggregates in regions without neurodegeneration and the sparsity of inclusions in lower motor neurons in cases with motor neuron disease support the conclusion that dipeptide repeat pathology is not the direct cause of neurodegeneration. |
Author | Mann, D. M. A. Hamdalla, H. Masuda-Suzukake, M. Tian, J. Richardson, A. Wu, D. Suzuki, G. Snowden, J. S. Liu, X. Hasegawa, M. Pickering-Brown, S. Ealing, J. Troakes, C. Nonaka, T. Davidson, Y. Shi, J. Jones, M. Robinson, A. C. Rollinson, S. |
AuthorAffiliation | 4 Clinical and Cognitive Sciences Research Group Institute of Brain, Behaviour and Mental Health Faculty of Medical and Human Sciences University of Manchester Manchester UK 7 Cerebral Function Unit Salford Royal Hospital Manchester UK 3 London Neurodegenerative Diseases Brain Bank Department of Basic and Clinical Neuroscience Institute of Psychiatry, Psychology and Neuroscience King's College London London UK 2 Beijing University of Chinese Medicine Dongzhimen Hospital Beijing China 6 Manchester MND Care Centre Salford Royal Hospital Manchester UK 1 Clinical and Cognitive Sciences Research Group Institute of Brain, Behaviour and Mental Health Faculty of Medical and Human Sciences University of Manchester Salford Royal Hospital Salford UK 5 Department of Neuropathology and Cell Biology Tokyo Metropolitan Institute of Medical Science Tokyo Japan |
AuthorAffiliation_xml | – name: 1 Clinical and Cognitive Sciences Research Group Institute of Brain, Behaviour and Mental Health Faculty of Medical and Human Sciences University of Manchester Salford Royal Hospital Salford UK – name: 4 Clinical and Cognitive Sciences Research Group Institute of Brain, Behaviour and Mental Health Faculty of Medical and Human Sciences University of Manchester Manchester UK – name: 2 Beijing University of Chinese Medicine Dongzhimen Hospital Beijing China – name: 5 Department of Neuropathology and Cell Biology Tokyo Metropolitan Institute of Medical Science Tokyo Japan – name: 6 Manchester MND Care Centre Salford Royal Hospital Manchester UK – name: 7 Cerebral Function Unit Salford Royal Hospital Manchester UK – name: 3 London Neurodegenerative Diseases Brain Bank Department of Basic and Clinical Neuroscience Institute of Psychiatry, Psychology and Neuroscience King's College London London UK |
Author_xml | – sequence: 1 givenname: Y. surname: Davidson fullname: Davidson, Y. organization: Clinical and Cognitive Sciences Research Group, Institute of Brain, Behaviour and Mental Health, Faculty of Medical and Human Sciences, University of Manchester, Salford Royal Hospital, Salford, UK – sequence: 2 givenname: A. C. surname: Robinson fullname: Robinson, A. C. organization: Clinical and Cognitive Sciences Research Group, Institute of Brain, Behaviour and Mental Health, Faculty of Medical and Human Sciences, University of Manchester, Salford Royal Hospital, Salford, UK – sequence: 3 givenname: X. surname: Liu fullname: Liu, X. organization: Clinical and Cognitive Sciences Research Group, Institute of Brain, Behaviour and Mental Health, Faculty of Medical and Human Sciences, University of Manchester, Salford Royal Hospital, Salford, UK – sequence: 4 givenname: D. surname: Wu fullname: Wu, D. organization: Clinical and Cognitive Sciences Research Group, Institute of Brain, Behaviour and Mental Health, Faculty of Medical and Human Sciences, University of Manchester, Salford Royal Hospital, Salford, UK – sequence: 5 givenname: C. surname: Troakes fullname: Troakes, C. organization: London Neurodegenerative Diseases Brain Bank, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK – sequence: 6 givenname: S. surname: Rollinson fullname: Rollinson, S. organization: Clinical and Cognitive Sciences Research Group, Institute of Brain, Behaviour and Mental Health, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK – sequence: 7 givenname: M. surname: Masuda-Suzukake fullname: Masuda-Suzukake, M. organization: Department of Neuropathology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan – sequence: 8 givenname: G. surname: Suzuki fullname: Suzuki, G. organization: Department of Neuropathology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan – sequence: 9 givenname: T. surname: Nonaka fullname: Nonaka, T. organization: Department of Neuropathology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan – sequence: 10 givenname: J. surname: Shi fullname: Shi, J. organization: Beijing University of Chinese Medicine, Dongzhimen Hospital, Beijing, China – sequence: 11 givenname: J. surname: Tian fullname: Tian, J. organization: Beijing University of Chinese Medicine, Dongzhimen Hospital, Beijing, China – sequence: 12 givenname: H. surname: Hamdalla fullname: Hamdalla, H. organization: Manchester MND Care Centre, Salford Royal Hospital, Manchester, UK – sequence: 13 givenname: J. surname: Ealing fullname: Ealing, J. organization: Manchester MND Care Centre, Salford Royal Hospital, Manchester, UK – sequence: 14 givenname: A. surname: Richardson fullname: Richardson, A. organization: Cerebral Function Unit, Salford Royal Hospital, Manchester, UK – sequence: 15 givenname: M. surname: Jones fullname: Jones, M. organization: Cerebral Function Unit, Salford Royal Hospital, Manchester, UK – sequence: 16 givenname: S. surname: Pickering-Brown fullname: Pickering-Brown, S. organization: Clinical and Cognitive Sciences Research Group, Institute of Brain, Behaviour and Mental Health, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK – sequence: 17 givenname: J. S. surname: Snowden fullname: Snowden, J. S. organization: Clinical and Cognitive Sciences Research Group, Institute of Brain, Behaviour and Mental Health, Faculty of Medical and Human Sciences, University of Manchester, Salford Royal Hospital, Salford, UK – sequence: 18 givenname: M. surname: Hasegawa fullname: Hasegawa, M. organization: Department of Neuropathology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan – sequence: 19 givenname: D. M. A. surname: Mann fullname: Mann, D. M. A. email: david.mann@manchester.ac.uk organization: Clinical and Cognitive Sciences Research Group, Institute of Brain, Behaviour and Mental Health, Faculty of Medical and Human Sciences, University of Manchester, Salford Royal Hospital, Salford, UK |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26538301$$D View this record in MEDLINE/PubMed |
BookMark | eNp1ks1uEzEQgFeoiKaFAy-ALHGBw7b-2T9fkKoABVGFIhVV4mJ5d2cTt7uere3Q5lV5GpykjSgIXyzL33wzHs9BsmfRQpK8ZPSIxXVstT1inEv-JJkwUeQpl5LuJRMqaJ6yKiv2kwPvryileVnIZ8k-L3JRCcomya8ZLB22MAcLTgeDlhhLOoc2YIBhRKd70mOtHXkEaduSAQM6YtcCC6Q1HrQHor3HxugALbk1YUHgbtTWxxi_Nk8luq7kxHjSG3sdoYDk4v15mgky6rDAHuerjd1i-Mel53MH8825Qzd4gl3MO8IYTAvEwQg6kNHFyo31z5Onne49vLjfD5PvHz9cTD-lZ19PP09PztImZxlP8yareQO863jbMlmXlcwryDuqy7qQDdVUZKyo8zrLdF2WNI_Nq2VdZFXGayZBHCbvtt5xWQ_QNmBDbJoanRm0WynURj2-sWah5vhTZZWIn1ZEwZt7gcObJfigBuMb6HttAZdesbKKWTMuq4i-_gu9wqWz8XmRKouSxR-WkXq7pRqH3jvodsUwqtYTo-LEqM3ERPbVn9XvyIcRicDxFrg1Paz-b1Kzk9mDMt1GGB_gbheh3bUqSlHm6nJ2qr6JH-LL-eVMSfEbfg3hdQ |
CODEN | NANEDL |
CitedBy_id | crossref_primary_10_1002_brb3_2881 crossref_primary_10_1038_s41398_019_0381_1 crossref_primary_10_1186_s40478_018_0629_7 crossref_primary_10_1093_brain_aww264 crossref_primary_10_15252_embj_2018100574 crossref_primary_10_1212_WNL_0000000000004865 crossref_primary_10_1007_s00401_018_1921_0 crossref_primary_10_1111_bpa_12486 crossref_primary_10_1093_brain_awad243 crossref_primary_10_1016_j_celrep_2023_112983 crossref_primary_10_1016_j_jmb_2023_168144 crossref_primary_10_1080_15548627_2021_1926656 crossref_primary_10_7554_eLife_62718 crossref_primary_10_1007_s12035_024_04187_4 crossref_primary_10_1038_s41580_021_00382_6 crossref_primary_10_1038_s41467_017_02643_5 crossref_primary_10_1186_s40478_019_0845_9 crossref_primary_10_1016_j_stem_2023_01_005 crossref_primary_10_1016_j_cell_2018_03_025 crossref_primary_10_1007_s00401_021_02399_9 crossref_primary_10_1016_j_mcn_2018_10_003 crossref_primary_10_15252_emmm_201910722 crossref_primary_10_1016_j_cortex_2019_11_022 crossref_primary_10_1186_s40478_019_0812_5 crossref_primary_10_1016_j_jns_2022_120221 crossref_primary_10_1186_s40478_020_01036_y crossref_primary_10_1038_nn_4272 crossref_primary_10_1016_j_neuron_2020_04_011 crossref_primary_10_1038_s42004_021_00547_6 crossref_primary_10_3389_fncel_2017_00195 crossref_primary_10_3389_fncel_2017_00196 crossref_primary_10_1016_j_nbd_2020_105055 crossref_primary_10_1001_jamaneurol_2017_4266 crossref_primary_10_1016_j_neurol_2024_03_008 crossref_primary_10_1093_jnen_nlad078 crossref_primary_10_1111_nan_12526 crossref_primary_10_1007_s00401_017_1793_8 crossref_primary_10_3389_fgene_2020_562758 crossref_primary_10_3389_fncel_2023_1247297 crossref_primary_10_1007_s00401_019_02028_6 crossref_primary_10_1038_s41467_023_41339_x crossref_primary_10_1016_j_gde_2017_01_006 crossref_primary_10_1186_s40478_018_0579_0 crossref_primary_10_1002_path_6008 crossref_primary_10_1007_s00401_019_02084_y crossref_primary_10_1038_s41582_018_0047_2 crossref_primary_10_15252_embj_2018101112 crossref_primary_10_1111_jnc_13623 crossref_primary_10_1111_nan_12296 crossref_primary_10_3989_redc_2017_2_1372 crossref_primary_10_1016_j_arr_2020_101172 crossref_primary_10_1111_jnc_13588 |
Cites_doi | 10.1126/science.1254917 10.1073/pnas.1315438110 10.1007/s00401-015-1429-9 10.1016/S1474-4422(14)70233-9 10.1126/science.1232927 10.1212/01.wnl.0000172911.39167.b6 10.1093/brain/awu120 10.1016/j.neuron.2013.02.004 10.1186/2051-5960-1-68 10.1007/s00401-015-1450-z 10.1007/s00401-014-1336-5 10.1186/s40478-015-0218-y 10.1007/s00401-013-1200-z 10.1093/brain/awr179 10.1016/j.neurobiolaging.2014.01.016 10.1007/s00401-014-1286-y 10.1016/j.neuron.2014.12.010 10.1371/journal.pgen.1002018 10.1007/s00401-013-1181-y 10.1016/j.ajhg.2013.04.017 10.1126/science.1256800 10.1016/j.neuron.2011.09.010 10.1016/j.neuron.2011.09.011 10.1007/s00401-014-1329-4 10.1016/S0021-9258(18)83694-8 10.1007/s00401-015-1401-8 10.1212/WNL.51.6.1546 10.1007/s00401-015-1476-2 10.1007/s00401-013-1237-z 10.1186/2051-5960-2-70 10.1136/jnnp.53.1.23 10.1007/s00401-013-1189-3 |
ContentType | Journal Article |
Copyright | 2015 The Authors. published by John Wiley & Sons Ltd on behalf of British Neuropathological Society. 2015 The Authors. Neuropathology and Applied Neurobiology published by John Wiley & Sons Ltd on behalf of British Neuropathological Society. Copyright © 2016 British Neuropathological Society |
Copyright_xml | – notice: 2015 The Authors. published by John Wiley & Sons Ltd on behalf of British Neuropathological Society. – notice: 2015 The Authors. Neuropathology and Applied Neurobiology published by John Wiley & Sons Ltd on behalf of British Neuropathological Society. – notice: Copyright © 2016 British Neuropathological Society |
DBID | BSCLL 24P WIN CGR CUY CVF ECM EIF NPM AAYXX CITATION 7TK K9. 5PM |
DOI | 10.1111/nan.12292 |
DatabaseName | Istex Wiley Online Library Open Access Wiley Online Library Free Content Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Neurosciences Abstracts ProQuest Health & Medical Complete (Alumni) PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Health & Medical Complete (Alumni) Neurosciences Abstracts |
DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) MEDLINE Neurosciences Abstracts |
Database_xml | – sequence: 1 dbid: 24P name: Wiley_OA刊 url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Y. Davidson et al |
EISSN | 1365-2990 |
EndPage | 254 |
ExternalDocumentID | 4003884901 10_1111_nan_12292 26538301 NAN12292 ark_67375_WNG_Q3Z3KPWN_9 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Alzheimer's Research UK – fundername: Medical Research Council – fundername: Alzheimer's Society – fundername: Institutions of Higher Education for Academic Disciplinary Innovations funderid: B08006 – fundername: Wellcome Trust funderid: 089701/Z/09/Z – fundername: Medical Research Council grantid: G9318379 – fundername: Wellcome Trust – fundername: Medical Research Council grantid: G1100695 – fundername: Wellcome Trust grantid: 089701/Z/09/Z – fundername: Medical Research Council grantid: MR/L016397/1 – fundername: Institutions of Higher Education for Academic Disciplinary Innovations grantid: B08006 |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 123 1OB 1OC 29N 31~ 33P 36B 3SF 3UE 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFZJQ AHBTC AHEFC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EAS EBC EBD EBS EBX EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA GSXLS H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO L7B LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 Q~Q R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 YFH ZGI ZXP ZZTAW ~IA ~WT 24P WIN CGR CUY CVF ECM EIF NPM AAMNL AAYXX ACRPL ACYXJ CITATION 7TK K9. 5PM |
ID | FETCH-LOGICAL-c5142-5c4b2ce2ff2dd19b78958e5f0a7b69c0a03416b5b44ab7705265b9b64842b19e3 |
IEDL.DBID | 24P |
ISSN | 0305-1846 |
IngestDate | Tue Sep 17 21:06:54 EDT 2024 Wed Dec 04 10:58:58 EST 2024 Thu Oct 10 16:25:00 EDT 2024 Fri Dec 06 01:33:18 EST 2024 Sat Sep 28 08:10:36 EDT 2024 Sat Aug 24 00:59:37 EDT 2024 Wed Oct 30 09:55:31 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | dipeptide repeat proteins TDP-43 motor neurone disease frontotemporal lobar degeneration C9orf72 |
Language | English |
License | Attribution 2015 The Authors. Neuropathology and Applied Neurobiology published by John Wiley & Sons Ltd on behalf of British Neuropathological Society. http://creativecommons.org/licenses/by/4.0 This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5142-5c4b2ce2ff2dd19b78958e5f0a7b69c0a03416b5b44ab7705265b9b64842b19e3 |
Notes | Wellcome Trust - No. 089701/Z/09/Z Medical Research Council istex:47FFFEE8E116AB8BA073BB09E23E43E7CE32BA49 ark:/67375/WNG-Q3Z3KPWN-9 Alzheimer's Society Figure S1. Specificity of antibodies for their antigenic protein as determined by ELISA, for anti GR (A), anti GP (B) anti AP and anti PR (both C) antibodies.Figure S2. Specificity of antibodies for their antigenic protein as determined by Western blotting of proteins extracted from cell lines expressing the relevant peptide.Table S1. selected clinical, neuropathological and genetic data on the 29 cases employed in the study.Table S2. Post hoc (Mann-Whitney) significance values for comparisons between scores for DPR immunostaining using antibodies against poly-GA, poly-GP and poly-GR proteins following attainment of significant difference when comparing scores for all three antibodies by Kruskal-Wallis test. Table S3. Significance values for comparisons of scores (by Mann-Whitney test) for DPR immunostaining in different brain regions using Manchester and Tokyo poly-GP, and Manchester and Tokyo poly-GR antibodies. Institutions of Higher Education for Academic Disciplinary Innovations - No. B08006 Alzheimer's Research UK ArticleID:NAN12292 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 The copyright line for this article was changed on March 30, 2016 after original online publication. |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fnan.12292 |
PMID | 26538301 |
PQID | 1776710579 |
PQPubID | 1096364 |
PageCount | 13 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4832296 proquest_miscellaneous_1780524298 proquest_journals_1776710579 crossref_primary_10_1111_nan_12292 pubmed_primary_26538301 wiley_primary_10_1111_nan_12292_NAN12292 istex_primary_ark_67375_WNG_Q3Z3KPWN_9 |
PublicationCentury | 2000 |
PublicationDate | April 2016 |
PublicationDateYYYYMMDD | 2016-04-01 |
PublicationDate_xml | – month: 04 year: 2016 text: April 2016 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Oxford – name: Hoboken |
PublicationTitle | Neuropathology and applied neurobiology |
PublicationTitleAlternate | Neuropathol Appl Neurobiol |
PublicationYear | 2016 |
Publisher | Blackwell Publishing Ltd Wiley Subscription Services, Inc John Wiley and Sons Inc |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley Subscription Services, Inc – name: John Wiley and Sons Inc |
References | Pearson CE. Repeat associated non-ATG translation initiation: one DNA, two transcripts, seven reading frames, potentially nine toxic entities!. PLoS Genet 2011; 7: e1002018 Rohrer JD, Isaacs AM, Mizielinska S, Mead S, Lashley T, Wray S, Sidle K, Fratta P, Orrell RW, Hardy J, Holton J, Revesz T, Rossor MN, Warren JD. C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis. Lancet Neurol 2015; 14: 291-301 Waite AJ, Bäumer D, East S, Neal J, Morris HR, Ansorge O, Blake DJ. Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion. Neurobiol Aging 2014; 35: 1779.e5-13 Mizielinska S, Gronke S, Niccoli T, Ridler CE, Clayton EL, Devoy A, Moens T, Norona FE, Woollacott IOC, Pietrzyk J, Cleverly K, Nicoll AJ, Pickering-Brown S, Dols J, Cabecinha M, Hendrich O, Fratta P, Fisher EMC, Partridge L. Isaacs AM (2014) C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science 2014; 345: 1192-4 Xi Z, Zinman L, Moreno D, Schymick J, Liang Y, Sato C, Zheng Y, Ghani M, Dib S, Keith J, Robertson J, Rogaeva E. Hypermethylation of the CpG Island near the GC repeat in ALS with a C9orf72 expansion. Am J Hum Genet 2013; 92: 981-9 Neary D, Snowden JS, Mann DMA, Northen B, Goulding PJ, MacDermott N. Frontal lobe dementia and motor neurone disease. J Neurol Neurosurg Psychiatry 1990; 53: 23-32 Gomez-Deza J, Lee Y-B, Troakes C, Nolan M, Al-Sarraj S, Gallo J-M, Shaw CE. Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutatant amyotrophic lateral sclerosis and are unlikely to cause their neurodgeneration. Acta Neuropathol Commun 2015; 3: 38 Ash PE, Bieniek KF, Gendron TF, Caulfield T, Lin WL, Dejesus-Hernandez M, van Blitterswijk MM, Jansen-West K, Paul JW 3rd, Rademakers R, Boylan KB, Dickson DW, Petrucelli L. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron 2013; 77: 639-46 Cooper-Knock J, Walsh MJ, Higginbottom A, Highley RJ, Dickman MJ, Edbauer D, Ince PG, Wharton SB, Wilson SA, Kirby J, Hautbergue GM, Shaw PJ. Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions. Brain 2014; 137: 2040-51 Mann DMA, Rollinson S, Robinson A, Callister J, Snowden JS, Gendron T, Petrucelli L, Masuda-Suzukake M, Hasegawa M, Davidson YS, Pickering-Brown S. Dipeptide repeat proteins are present in the p62 positive inclusions in patients with Frontotemporal Lobar Degeneration and Motor Neurone Disease associated with expansions in C9ORF72. Acta Neuropathol Commun 2013; 1: 68 Mackenzie IR, Arzberger T, Kremmer E, Troost D, Lorenzl S, Mori K, Weng SM, Haass C, Kretzschmar HA, Edbauer D, Neumann M. Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations. Acta Neuropathol 2013; 126: 859-79 Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546-54 Peabody DS. Translation initiation at non-AUG triplets in mammalian cells. J Biol Chem 1989; 264: 5031-5 Zu T, Liu Y, Banez-Coronel M, Reid T, Pletnikova O, Lewis J, Miller TM, Harms MB, Falchook AE, Subramony SH, Ostrow LW, Rothstein JD, Troncoso JC. Ranum LP (2013) RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc Natl Acad Sci U S A 2013; 110: E4968-77 Mori K, Weng SM, Arzberger T, May S, Rentzsch K, Kremmer E, Schmid B, Kretzschmar HA, Cruts M, Van Broeckhoven C, Haass C, Edbauer D. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science 2013; 339: 1335-8 May S, Hornburg D, Schludi MH, Arzberger T, Rentzsch K, Scwenk BM, Grasser FA, Mori K, Kremmer E, Banzhaf-Strathmann J, Mann M, Meissner F, Edbauer D. C9orf72 FTLD/ALS-associated Gly-Alal dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration. Acta Neuropathol 2014; 128: 485-503 Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 2005; 65: 586-90 Davidson Y, Barker H, Robinson AC, Troakes C, Smith B, Al-Saraj S, Shaw C, Rollinson S, Masuda-Suzukake M, Hasegawa M, Pickering-Brown S, Snowden JS, Mann DMA. Brain distribution of dipeptide repeat proteins in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72. Acta Neuropathol Commun 2014; 2: 70 Gendron TF, Belzil VV, Zhang Y-J, Petrucelli L. Mechanisms of toxicity in C9FTLD/ALS. Acta Neuropathol 2014; 127: 359-76 Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, van Swieten JC, Seelaar H, Dopper EG, Onyike CU, Hillis AE, Josephs KA, Boeve BF, Kertesz A, Seeley WW, Rankin KP, Johnson JK, Gorno-Tempini ML, Rosen H, Prioleau-Latham CE, Lee A, Kipps CM, Lillo P, Piguet O, Rohrer JD, Rossor MN, Warren JD, Fox NC, Galasko D, Salmon DP, Black SE, Mesulam M, Weintraub S, Dickerson BC, Diehl-Schmid J, Pasquier F, Deramecourt V, Lebert F, Pijnenburg Y, Chow TW, Manes F, Grafman J, Cappa SF, Freedman M, Grossman M, Miller BL. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011; 134: 2456-77 Liu EY, Russ J, Wu K, Neal D, Suh E, McNally AG, Irwin DJ, Van Deerlin VM, Lee EB. C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD. Acta Neuropathol 2014; 128: 525-41 Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial 'Clinical limits of amyotrophic lateral sclerosis' workshop contributors. J Neurol Sci 1994; 124 (Suppl.): 96-107 Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, Kalimo H, Paetau A, Abramzon Y, Remes AM, Kaganovich A, Scholz SW, Duckworth J, Ding J, Harmer DW, Hernandez DG, Johnson JO, Mok K, Ryten M, Trabzuni D, Guerreiro RJ, Orrell RW, Neal J, Murray A, Pearson J, Jansen IE, Sondervan D, Seelaar H, Blake D, Young K, Halliwell N, Callister JB, Toulson G, Richardson A, Gerhard A, Snowden J, Mann D, Neary D, Nalls MA, Peuralinna T, Jansson L, Isoviita VM, Kaivorinne AL, Holtta-Vuori M, Ikonen E, Sulkava R, Benatar M, Wuu J, Chio A, Restagno G, Borghero G, Sabatelli M, Heckerman D, Rogaeva E, Zinman L, Rothstein JD, Sendtner M, Drepper C, Eichler EE, Alkan C, Abdullaev Z, Pack SD, Dutra A, Pak E, Hardy J, Singleton A, Williams NM, Heutink P, Pickering-Brown S, Morris HR, Tienari PJ, Traynor BJ. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011; 72: 257-68 Mizielinska S, Lashley T, Norona FE, Clayton EL, Ridler CE, Fratta P, Isaacs AM. C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci. Acta Neuropathol 2013; 126: 845-58 Wen X, Tan W, Westergard T, Krishnamurthy K, Markandaiah SS, Shi Y, Lin S, Shneider NA, Monaghan J, Pandey UB, Pasinelli P, Ichida JK, Trotti D. Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death. Neuron 2014; 84: 1213-25 DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, Kouri N, Wojtas A, Sengdy P, Hsiung GY, Karydas A, Seeley WW, Josephs KA, Coppola G, Geschwind DH, Wszolek ZK, Feldman H, Knopman DS, Petersen RC, Miller BL, Dickson DW, Boylan KB, Graff-Radford NR, Rademakers R. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011; 72: 245-56 Zhang YJ, Jansen-West K, Xu YF, Gendron TF, Bieniek KF, Lin WL, Sasaguri H, Caulfield T, Hubbard J, Daughrity L, Chew J, Belzil VV, Prudencio M, Stankowski JN, Castanedes-Casey M, Whitelaw E, Ash PE, DeTure M, Rademakers R, Boylan KB, Dickson DW, Petrucelli L. Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress. Acta Neuropathol 2014; 128: 505-24 Mackenzie IR, Frick P, Grässer FA, Gendron TF, Petrucelli L, Cashman NR, Edbauer D, Kremmer E, Prudlo J, Troost D, Neumann M. Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers. Acta Neuropathol 2015; 130: 845-861 Mori K, Arzberger T, Grasser FA, Gijselinck I, May S, Rentzsch K, Weng SM, Schludi MH, van der Zee J, Cruts M, Van Broeckhoven C, Kremmer E, Kretzschmar HA, Haass C, Edbauer D. Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol 2013; 126: 881-94 Xi Z, Zhang M, Bruni AC, Maletta RG, Colao R, Fratta P, Polke JM, Sweeney MG, Mudanohwo E, Nacmias B, Sorbi S, Tartaglia MC, Rainero I, Rubino E, Pinessi L, Galimberti D, Surace EI, McGoldrick P, McKeever P, Moreno D, Sato C, Liang Y, Keith J, Zinman L, Robertson J, Rogaeva E. The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients. Acta Neuropathol 2015; 129: 715-28 Schludi MH, May S, Grässer FA, Rentzsch K, Kremmer E, Küpper C, Klopstock T; German Consortium for Frontotemporal Lobar Degeneration; Bavarian Brain Banking Alliance, Arzberger T, Edbauer D. Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing. Acta Neuropathol 2015; 130: 537-555 Kwon I, Xiang S, Kato M, Wu L, Theodoropoulos P, Wang T, Kim J, Yun J, Xie Y, McKnight SL. Poly-dipeptides encoded by the C9orf72 repeats bind nuc 1990; 53 2015; 14 2013; 1 2015; 3 2013; 126 2013; 92 2005; 65 2015; 129 2014; 84 2011; 134 2014; 137 2011; 7 2015; 130 1994; 124 2014; 127 2014; 128 2014; 2 2013; 77 2013; 339 1989; 264 2011; 72 2014; 35 2013; 110 1998; 51 2014; 345 e_1_2_8_28_1 e_1_2_8_24_1 e_1_2_8_25_1 e_1_2_8_26_1 e_1_2_8_27_1 e_1_2_8_3_1 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_7_1 e_1_2_8_6_1 e_1_2_8_9_1 e_1_2_8_8_1 Brooks BR (e_1_2_8_29_1) 1994; 124 e_1_2_8_20_1 e_1_2_8_21_1 e_1_2_8_22_1 e_1_2_8_23_1 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_14_1 e_1_2_8_15_1 e_1_2_8_16_1 e_1_2_8_32_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_11_1 e_1_2_8_34_1 e_1_2_8_12_1 e_1_2_8_33_1 e_1_2_8_30_1 |
References_xml | – volume: 126 start-page: 845 year: 2013 end-page: 58 article-title: C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci publication-title: Acta Neuropathol – volume: 128 start-page: 485 year: 2014 end-page: 503 article-title: C9orf72 FTLD/ALS‐associated Gly‐Alal dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration publication-title: Acta Neuropathol – volume: 53 start-page: 23 year: 1990 end-page: 32 article-title: Frontal lobe dementia and motor neurone disease publication-title: J Neurol Neurosurg Psychiatry – volume: 110 start-page: E4968 year: 2013 end-page: 77 article-title: Ranum LP (2013) RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia publication-title: Proc Natl Acad Sci U S A – volume: 72 start-page: 245 year: 2011 end-page: 56 article-title: Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p‐linked FTD and ALS publication-title: Neuron – volume: 130 start-page: 845 year: 2015 end-page: 861 article-title: Quantitative analysis and clinico‐pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers publication-title: Acta Neuropathol – volume: 134 start-page: 2456 year: 2011 end-page: 77 article-title: Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia publication-title: Brain – volume: 126 start-page: 859 year: 2013 end-page: 79 article-title: Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico‐pathological correlations publication-title: Acta Neuropathol – volume: 126 start-page: 881 year: 2013 end-page: 94 article-title: Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins publication-title: Acta Neuropathol – volume: 128 start-page: 505 year: 2014 end-page: 24 article-title: Aggregation‐prone c9FTD/ALS poly(GA) RAN‐translated proteins cause neurotoxicity by inducing ER stress publication-title: Acta Neuropathol – volume: 2 start-page: 70 year: 2014 article-title: Brain distribution of dipeptide repeat proteins in frontotemporal lobar degeneration and motor neurone disease associated with expansions in publication-title: Acta Neuropathol Commun – volume: 72 start-page: 257 year: 2011 end-page: 68 article-title: A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21‐linked ALS‐FTD publication-title: Neuron – volume: 65 start-page: 586 year: 2005 end-page: 90 article-title: Prevalence and patterns of cognitive impairment in sporadic ALS publication-title: Neurology – volume: 84 start-page: 1213 year: 2014 end-page: 25 article-title: Antisense proline‐arginine RAN dipeptides linked to C9ORF72‐ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death publication-title: Neuron – volume: 127 start-page: 359 year: 2014 end-page: 76 article-title: Mechanisms of toxicity in C9FTLD/ALS publication-title: Acta Neuropathol – volume: 339 start-page: 1335 year: 2013 end-page: 8 article-title: The C9orf72 GGGGCC repeat is translated into aggregating dipeptide‐repeat proteins in FTLD/ALS publication-title: Science – volume: 14 start-page: 291 year: 2015 end-page: 301 article-title: C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis publication-title: Lancet Neurol – volume: 345 start-page: 1139 year: 2014 end-page: 45 article-title: Poly‐dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells publication-title: Science – volume: 51 start-page: 1546 year: 1998 end-page: 54 article-title: Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria publication-title: Neurology – volume: 35 start-page: 1779.e5 year: 2014 end-page: 13 article-title: Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion publication-title: Neurobiol Aging – volume: 137 start-page: 2040 year: 2014 end-page: 51 article-title: Sequestration of multiple RNA recognition motif‐containing proteins by C9orf72 repeat expansions publication-title: Brain – volume: 130 start-page: 537 year: 2015 end-page: 555 article-title: Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing publication-title: Acta Neuropathol – volume: 130 start-page: 63 year: 2015 end-page: 75 article-title: Antisense RNA foci in the motor neurones of ‐ALS patients are associated with TDP‐43 proteinopathy publication-title: Acta Neuropathol – volume: 264 start-page: 5031 year: 1989 end-page: 5 article-title: Translation initiation at non‐AUG triplets in mammalian cells publication-title: J Biol Chem – volume: 128 start-page: 525 year: 2014 end-page: 41 article-title: C9orf72 hypermethylation protects against repeat expansion‐associated pathology in ALS/FTD publication-title: Acta Neuropathol – volume: 77 start-page: 639 year: 2013 end-page: 46 article-title: Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS publication-title: Neuron – volume: 1 start-page: 68 year: 2013 article-title: Dipeptide repeat proteins are present in the p62 positive inclusions in patients with Frontotemporal Lobar Degeneration and Motor Neurone Disease associated with expansions in C9ORF72 publication-title: Acta Neuropathol Commun – volume: 7 start-page: e1002018 year: 2011 article-title: Repeat associated non‐ATG translation initiation: one DNA, two transcripts, seven reading frames, potentially nine toxic entities! publication-title: PLoS Genet – volume: 129 start-page: 715 year: 2015 end-page: 28 article-title: The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients publication-title: Acta Neuropathol – volume: 3 start-page: 38 year: 2015 article-title: Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutatant amyotrophic lateral sclerosis and are unlikely to cause their neurodgeneration publication-title: Acta Neuropathol Commun – volume: 92 start-page: 981 year: 2013 end-page: 9 article-title: Hypermethylation of the CpG Island near the GC repeat in ALS with a C9orf72 expansion publication-title: Am J Hum Genet – volume: 345 start-page: 1192 year: 2014 end-page: 4 article-title: Isaacs AM (2014) repeat expansions cause neurodegeneration in through arginine‐rich proteins publication-title: Science – volume: 124 start-page: 96 issue: Suppl. year: 1994 end-page: 107 article-title: El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial ‘Clinical limits of amyotrophic lateral sclerosis’ workshop contributors publication-title: J Neurol Sci – ident: e_1_2_8_21_1 doi: 10.1126/science.1254917 – ident: e_1_2_8_15_1 doi: 10.1073/pnas.1315438110 – ident: e_1_2_8_10_1 doi: 10.1007/s00401-015-1429-9 – ident: e_1_2_8_34_1 doi: 10.1016/S1474-4422(14)70233-9 – ident: e_1_2_8_14_1 doi: 10.1126/science.1232927 – ident: e_1_2_8_26_1 doi: 10.1212/01.wnl.0000172911.39167.b6 – ident: e_1_2_8_9_1 doi: 10.1093/brain/awu120 – ident: e_1_2_8_11_1 doi: 10.1016/j.neuron.2013.02.004 – ident: e_1_2_8_12_1 doi: 10.1186/2051-5960-1-68 – ident: e_1_2_8_17_1 doi: 10.1007/s00401-015-1450-z – ident: e_1_2_8_18_1 doi: 10.1007/s00401-014-1336-5 – ident: e_1_2_8_33_1 doi: 10.1186/s40478-015-0218-y – ident: e_1_2_8_8_1 doi: 10.1007/s00401-013-1200-z – ident: e_1_2_8_28_1 doi: 10.1093/brain/awr179 – ident: e_1_2_8_4_1 doi: 10.1016/j.neurobiolaging.2014.01.016 – ident: e_1_2_8_7_1 doi: 10.1007/s00401-014-1286-y – ident: e_1_2_8_20_1 doi: 10.1016/j.neuron.2014.12.010 – ident: e_1_2_8_32_1 doi: 10.1371/journal.pgen.1002018 – ident: e_1_2_8_22_1 doi: 10.1007/s00401-013-1181-y – volume: 124 start-page: 96 year: 1994 ident: e_1_2_8_29_1 article-title: El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial ‘Clinical limits of amyotrophic lateral sclerosis’ workshop contributors publication-title: J Neurol Sci contributor: fullname: Brooks BR – ident: e_1_2_8_5_1 doi: 10.1016/j.ajhg.2013.04.017 – ident: e_1_2_8_19_1 doi: 10.1126/science.1256800 – ident: e_1_2_8_2_1 doi: 10.1016/j.neuron.2011.09.010 – ident: e_1_2_8_3_1 doi: 10.1016/j.neuron.2011.09.011 – ident: e_1_2_8_16_1 doi: 10.1007/s00401-014-1329-4 – ident: e_1_2_8_31_1 doi: 10.1016/S0021-9258(18)83694-8 – ident: e_1_2_8_6_1 doi: 10.1007/s00401-015-1401-8 – ident: e_1_2_8_27_1 doi: 10.1212/WNL.51.6.1546 – ident: e_1_2_8_24_1 doi: 10.1007/s00401-015-1476-2 – ident: e_1_2_8_30_1 doi: 10.1007/s00401-013-1237-z – ident: e_1_2_8_23_1 doi: 10.1186/2051-5960-2-70 – ident: e_1_2_8_25_1 doi: 10.1136/jnnp.53.1.23 – ident: e_1_2_8_13_1 doi: 10.1007/s00401-013-1189-3 |
SSID | ssj0005769 |
Score | 2.422526 |
Snippet | Aims
A hexanucleotide expansion in C9orf72 is the major genetic cause of inherited behavioural variant Frontotemporal dementia (bvFTD) and motor neurone... A hexanucleotide expansion in C9orf72 is the major genetic cause of inherited behavioural variant Frontotemporal dementia (bvFTD) and motor neurone disease... Aims A hexanucleotide expansion in C9orf72 is the major genetic cause of inherited behavioural variant Frontotemporal dementia (bvFTD) and motor neurone... |
SourceID | pubmedcentral proquest crossref pubmed wiley istex |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 242 |
SubjectTerms | Aged C9orf72 C9orf72 Protein dipeptide repeat proteins Dipeptides DNA Repeat Expansion DNA-Binding Proteins - metabolism Female frontotemporal lobar degeneration Frontotemporal Lobar Degeneration - genetics Frontotemporal Lobar Degeneration - pathology Humans Immunohistochemistry Inclusion Bodies - metabolism Inclusion Bodies - pathology Male Middle Aged Motor Neuron Disease - genetics Motor Neuron Disease - pathology motor neurone disease Nerve Degeneration - genetics Nerve Degeneration - pathology Neurons - pathology Original Pathology Proteins Proteins - genetics Spinal cord TDP-43 |
Title | Neurodegeneration in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9orf72 is linked to TDP-43 pathology and not associated with aggregated forms of dipeptide repeat proteins |
URI | https://api.istex.fr/ark:/67375/WNG-Q3Z3KPWN-9/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fnan.12292 https://www.ncbi.nlm.nih.gov/pubmed/26538301 https://www.proquest.com/docview/1776710579 https://search.proquest.com/docview/1780524298 https://pubmed.ncbi.nlm.nih.gov/PMC4832296 |
Volume | 42 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9UwFA9jA_FFnJ91H0QR8aXSjzRp8GlszqGsXGVjw5eStMndRUkv7R3s0T_BP9Cn_SU7J-2tu0zBl9KS04T0fCY5_R1CXstKQpTMVcgQ_5JV0oQ6ExFcImEzqYWM8H_n44IfnbJP59n5Gnm__Bemx4cYN9xQM7y9RgVXurul5E65d3GSSLC_GxDWcCxfkLDJn_wO4evZoUCHsIzhA6wQpvGMr644ow38rld_izTvJkzeDmS9Jzp8SB4MISTd63m-SdaMe0TuHQ-H5I_Jbw-4UZupR5TGD09njlqPVDAgUf2giAPS0hUi5WoKjGta6kEunaHD6Q1VAw9NTXHflporsCG4zdZhz_uyaa1I6KyjeBwMRIuGnhxMrn_-YinFksd-697375rFnd7UFNb8U_-MEXRHGwsjzzHdpja0NXNwF9TjScxc94ScHn442T8KhyIOYQWxGCx0K6aTyiTWJnUdA_NzmeUms5ESmssqUhH4Ua4zzZjSQiD8TKal5ixniY6lSZ-SdQdTfk4oU5IJXuUiTQ3LTJ6nSlQ2VpYbZXUtAvJqyc1y3mN1lMs1DrC89CwPyBvP55FCtd8xuU1k5VnxsfySfks_T86KUgZkeykI5aDXXRkj-BGWRobml2MzaCQesyhnmkukwTIR4OfzgDzr5WYcDCaX5mBTAyJWJGokQLTv1RY3u_Co3wxtr-QBeetl798zLIu9wt-8-H_SLXIfIkHepyRtk_VFe2l2INpa6F2vVXA9-JrcAKctLIw |
link.rule.ids | 230,314,780,784,885,1375,11562,27924,27925,46052,46294,46476,46718 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqVgIuvB8pBQxCiEtWeThxLHGpWspCu1FBW7VCQpGdOMuqlbNKdqWKEz-BH8iJX8KMkw1dChLissrKE0cTfzMeeyafCXkucgFRcixdhvyXLBfaVRH34MfjZSQUFx5-7zxK4-ERe3cSnayRV8tvYVp-iH7DDS3D-ms0cNyQvmDlRpqBHwQCHPAGmLuPBV27H36RR0EkLdocQuTCOibueIWwjqe_dWU22sAXe_6nUPNyxeTFSNZORXs3yKelEm0FyulgMVeD_Mtv_I7_q-VNcr2LUel2C6pbZE2b2-TKqMvC3yHfLaNHoSeWshpHlk4NLS0VQkd1dUaRaKSmK0LSFBSQUdXUsmgaTbv0EJUdSHRBcWOY6nNwUriP12DPO6KqSx7QaUMx3wxC84qOdw9_fP3GQopnKtvcgO3fVPNLvcnJpNYT-x9D9IZWJTx5hvU8haa1nsF8RC1hxdQ0d8nR3uvxztDtTolwcwj2YCWdMxXkOijLoCh8QFciokRHpSe5ikXuSQ8m6lhFijGpOEd-m0gJFbOEBcoXOrxH1g2o_IBQJgXjcZ7wMNQs0kkSSp6XvixjLUtVcIc8W6Ilm7VkINlyEQXjlNlxcsgLi6NeQtanWD3Ho-w4fZO9Dz-G-4fHaSYcsrUEWtY5jibzkV0Jz16G5qd9M5g85nGk0dUCZfAcCggkEofcb3HZPwyUCxNw2g7hK4jtBZBOfLXFTD9bWnGGzl3EDnlpAfl3DbN0O7UXm_8u-oRcHY5HB9nB23T_IbkGYWfc1j9tkfV5vdCPILSbq8fWgn8CBM9PyQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELemTZp44f-fwACDEOKlU5o4diyeppUyGIsK2rQJTYrsxC7VkFOlrTTxxEfgA_LEJ-HOScPKQEK8VKl8cXTx785n3-VnQp7JQkKUzFWPIf8lK6Tp6USE8BMKm0gtZIjfOx9kfO-IvT1JTtbIy-W3MA0_RLfhhpbh_TUa-LS0F4zcKbfdjyIJ_neD8Ugicf7gwy_uKAikZZNCSHqwjOEtrRCW8XS3rkxGG_hez_8UaV4umLwYyPqZaHiNnC51aApQzrYXc71dfPmN3vE_lbxOrrYRKt1pIHWDrBl3k2wetDn4W-S75_MozdgTVuO40omj1hMhtERXnynSjNR0RUi5kgIuqpp6Dk1naJscoqqFiCkpbgtTcw4uCnfxZtjzrqxqKyI6mVHMNoPQvKKHg9GPr99YTPFEZZ8Z8P27an6pNzUe12bs_2OAPqOVhSdPsZqnNLQ2U5iNqKermLjZbXI0fHW4u9drz4joFRDqwTq6YDoqTGRtVJZ9wFYqk9QkNlRCc1mEKoRpmutEM6a0EMhuk2ipOUtZpPvSxHfIugOV7xHKlGSCF6mIY8MSk6axEoXtK8uNsroUAXm6BEs-bahA8uUSCsYp9-MUkOceRp2Eqs-wdk4k-XH2On8ff4z3R8dZLgOytcRZ3rqNWd5HbiU8eRman3TNYPCYxVHOVAuUwVMoIIxIA3K3gWX3MFAuTsFlB0SsALYTQDLx1RY3-eRJxRm6dskD8sLj8e8a5tlO5i_u_7voY7I5Ggzzd2-y_QfkCsScvCl-2iLr83phHkJcN9ePvP3-BO4DTng |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neurodegeneration+in+frontotemporal+lobar+degeneration+and+motor+neurone+disease+associated+with+expansions+in+C9orf72+is+linked+to+TDP-43+pathology+and+not+associated+with+aggregated+forms+of+dipeptide+repeat+proteins&rft.jtitle=Neuropathology+and+applied+neurobiology&rft.au=Davidson%2C+Y.&rft.au=Robinson%2C+A.+C.&rft.au=Liu%2C+X.&rft.au=Wu%2C+D.&rft.date=2016-04-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=0305-1846&rft.eissn=1365-2990&rft.volume=42&rft.issue=3&rft.spage=242&rft.epage=254&rft_id=info:doi/10.1111%2Fnan.12292&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_WNG_Q3Z3KPWN_9 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0305-1846&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0305-1846&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0305-1846&client=summon |